• Skip to main content

DistilINFO POPHealth

Daily News on Population Health.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Schooner Strategies Launches Population Health Outcomes Solution

Share:

August 2, 2019

Schooner Strategies is now offering a breakthrough solution powered by Trajectory® Healthcare LLC using advanced epidemiological and statistical verification methods to demonstrate healthcare outcomes.

ANNAPOLIS, Md., July 31, 2019 /PRNewswire-PRWeb/ — Schooner Strategies is now offering a breakthrough solution powered by Trajectory® Healthcare, LLC using advanced epidemiological and statistical verification methods to demonstrate healthcare outcomes.

“The new Trajectory application uses a patented process to create and study ‘virtual epidemics’ to examine a wide-variety of programs,” notes Garry Carneal, JD, MA, Schooner Strategies, President & CEO. “Schooner can now provide critical feedback loops that prove the value of telehealth, care management and other interventions. Using the Trajectory platform, we can provide an outcomes assessment in weeks, not months which is targeted to specific populations that the client is supporting.”

“We leverage the best of epidemiology science and statistical evaluation to provide critical feedback loops that demonstrate a link between programs and outcomes,” states Tom Wilson, PhD, DrPH, Trajectory HealthCare’s Founder and Schooner’s Chief Science Officer. He adds. “Many information sources help power this analysis, including medical and RX claims, lab results and patient surveys. The Trajectory data analytic engine creates and customizes study designs that validate the impact of interventions more accurately than other evaluation approaches or tools.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Trajectory evaluates the “cause and effect” of an intervention by controlling for the confounding variable of time. This approach adds clarity and fidelity to the analysis that other approaches cannot replicate. A demo of the Trajectory data analytic engine, combined with our wrap-around consulting services, will show you the current value of your program and provide insights on how to support future growth and improvement.

“Healthcare organizations must move quickly to assess the clinical and financial efficacy of their programs and product solutions, notes Monique Yohanan, MD, Schooner’s Chief Medical Officer. “Once a study is designed, metrics described, and data prepared in a structured format, a full report based on retrospective data can be analyzed and a report delivered very quickly. This is accomplished by software that has been developed based on over two decades of real-world experience in the health care space. This new solution is a perfect way to create, maintain and update evidence-based pathways.”

Schooner clients can access Trajectory’s secure online portal and subject matter experts who offer insightful and objective consulting services. We can help you share your results by drafting scientific publications, white papers, press releases and other communications. In addition, our Return on Investment (ROI) Calculator can examine the financial and clinical efficacy of most medical interventions in almost real time. We can address “what if” scenarios to examine the ROI for sub-populations and help you identify new opportunities.

To learn more about the new Outcomes Solution, click here. Check out our three sample case studies on the website!

The Schooner Strategies team often serves as a client’s extended staff and brings a combined source of dynamic talent to boost clients’ profits and gain industry-wide recognition.

Date: August 02, 2019

Source: Yahoo

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • AHIP Program Points to Health IT, EHRS for Prior AuthorizationAHIP Program Points to Health IT, EHRS for Prior Authorization
  • Population Genomic Screening Efforts May Identify High-Risk Individuals Before Disease OnsetPopulation Genomic Screening Efforts May Identify High-Risk Individuals Before Disease Onset
  • MA Special Needs Plans May Lower ESRD Spending, Improve OutcomesMA Special Needs Plans May Lower ESRD Spending, Improve Outcomes
  • AI, Technology Key to Reducing Medicare Fraud and Waste, CMS SaysAI, Technology Key to Reducing Medicare Fraud and Waste, CMS Says
  • EHR Investments Increase as Governments and Healthcare Authorities Focus on InteroperabilityEHR Investments Increase as Governments and Healthcare Authorities Focus on Interoperability
  • Health Systems Boost Patient Data Access with Apple Health RecordsHealth Systems Boost Patient Data Access with Apple Health Records
  • NextGen analytics tool intended to relate quality to cost of careNextGen analytics tool intended to relate quality to cost of care
  • Startup Seeks to Hold Doctors, Hospitals Accountable on Patient Record RequestsStartup Seeks to Hold Doctors, Hospitals Accountable on Patient Record Requests

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications